West Pharmaceutical Services (WST) Inventory Average (2010 - 2026)

West Pharmaceutical Services has disclosed Inventory Average across 17 years of filings, most recently posting $450.0 million for Q2 2026.

• In Q2 2026, Inventory Average rose 11.14% year-over-year to $450.0 million; the TTM figure through Jun 2026 stood at $450.0 million (up 11.14% YoY), while the FY2025 annual figure was $410.4 million, up 1.13% from the prior year.
• Inventory Average came in at $450.0 million for Q2 2026 at West Pharmaceutical Services, roughly flat from $448.2 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $450.0 million in Q2 2026 to a low of $382.8 million in Q1 2025.
• Average Inventory Average over 5 years is $422.4 million, with a median of $427.0 million recorded in 2024.
• Year-over-year, Inventory Average gained 26.35% in 2022 and declined 11.44% in 2025.
• Over 5 years, Inventory Average stood at $414.0 million in 2022, then grew by 4.66% to $433.2 million in 2023, then slipped by 10.19% to $389.1 million in 2024, then increased by 13.33% to $441.0 million in 2025, then increased by 2.05% to $450.0 million in 2026.
• Per Business Quant data, the three most recent Inventory Average figures were $450.0 million in Q2 2026, $448.2 million in Q1 2026, and $441.0 million in Q4 2025.